Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
The L.A. Report is a breakdown of the day's top news from Southern California, featuring the award-winning reporting of LAist 89.3 FM – L.A.'s number one NPR station. Hosted by Austin Cross in the ...
Music lovers from 89.3 The Current comb through mountains of music to choose the best new, independent, and unreleased songs to share with you each weekday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results